Inventor · disambiguated record
Lior Arazi
Also filed as: ARAZI LIOR
16 granted patents·19 pending applications·85 citations·filing 2004–2025
89Inventor score
Top patents by PatentIndex Score
35 records- 0191US11964168B2Diffusing alpha-emitter radiation therapy for prostate cancerALPHA TAU MEDICAL LTD·Filed 2023·Granted Apr 23, 2024·2 cites·10 claims
- 0289US8834837B2Method and device for radiotherapyKELSON ITZHAK·Filed 2009·Granted Sep 16, 2014·55 cites·27 claims
- 0386US8894969B2Method and device for radiotherapyKELSON ITZHAK·Filed 2004·Granted Nov 25, 2014·23 cites·14 claims
- 0478US12246191B2Diffusing alpha-emitter radiation therapy with enhanced beta treatmentALPHA TAU MEDICAL LTD·Filed 2023·Granted Mar 11, 2025·0 cites·20 claims
- 0577US12434073B2Diffusing alpha-emitter radiation therapy for prostate cancerALPHA TAU MEDICAL LTD·Filed 2024·Granted Oct 7, 2025·0 cites·6 claims
- 0671US11857803B2Diffusing alpha-emitter radiation therapy with enhanced beta treatmentALPHA TAU MEDICAL LTD·Filed 2021·Granted Jan 2, 2024·0 cites·32 claims
- 0770US12076582B2Diffusing alpha-emitter radiation therapy for colorectal cancerALPHA TAU MEDICAL LTD·Filed 2023·Granted Sep 3, 2024·0 cites·7 claims
- 0870US12070620B2Activity levels for diffusing alpha-emitter radiation therapyALPHA TAU MEDICAL LTD·Filed 2023·Granted Aug 27, 2024·0 cites·4 claims
- 0970US12064643B2Diffusing alpha-emitter radiation therapy for breast cancerALPHA TAU MEDICAL LTD·Filed 2023·Granted Aug 20, 2024·0 cites·10 claims
- 1069US12076583B2Diffusing alpha-emitter radiation therapy for melanomaALPHA TAU MEDICAL LTD·Filed 2023·Granted Sep 3, 2024·0 cites·7 claims
- 1169US12076581B2Diffusing alpha-emitter radiation therapy for glioblastomaALPHA TAU MEDICAL LTD·Filed 2023·Granted Sep 3, 2024·0 cites·6 claims
- 1269US12070621B2Diffusing alpha-emitter radiation therapy for pancreatic cancerALPHA TAU MEDICAL LTD·Filed 2023·Granted Aug 27, 2024·0 cites·7 claims
- 1369US2024374920A1Diffusing alpha-emitter radiation therapy for pancreatic cancerALPHA TAU MEDICAL LTD·Filed 2024·Application pending·0 cites
- 1469US2024382779A1Diffusing alpha-emitter radiation therapy for colorectal cancerALPHA TAU MEDICAL LTD·Filed 2024·Application pending·0 cites
- 1569US2024382780A1Diffusing alpha-emitter radiation therapy for melanomaALPHA TAU MEDICAL LTD·Filed 2024·Application pending·0 cites
- 1669US2024374921A1Diffusing alpha-emitter radiation therapy for glioblastomaALPHA TAU MEDICAL LTD·Filed 2024·Application pending·0 cites
- 1769US2024374922A1Diffusing alpha-emitter radiation therapy for breast cancerALPHA TAU MEDICAL LTD·Filed 2024·Application pending·0 cites
- 1869US2024374919A1Activity levels for diffusing alpha-emitter radiation therapyALPHA TAU MEDICAL LTD·Filed 2024·Application pending·0 cites
- 1969US2025367470A1Diffusing Alpha-emitter Radiation Therapy with Enhanced Beta TreatmentALPHA TAU MEDICAL LTD·Filed 2025·Application pending·0 cites
- 2068US10058713B2Method and device for radiotherapyALTHERA MEDICAL LTD·Filed 2014·Granted Aug 28, 2018·5 cites·21 claims
- 2165US2024238457A1Gel Loaded with Alpha-Emitter RadionuclidesALPHA TAU MEDICAL LTD·Filed 2024·Application pending·0 cites
- 2260US11666782B2Treatment planning for alpha particle radiotherapyALPHA TAU MEDICAL LTD·Filed 2021·Granted Jun 6, 2023·0 cites·24 claims
- 2359US12042668B2Diffusing alpha-emitter radiation therapy for squamous cell carcinomaALPHA TAU MEDICAL LTD·Filed 2023·Granted Jul 23, 2024·0 cites·11 claims
- 2459US2018345038A1Method and device for radiotherapyALPHA TAU MEDICAL LTD·Filed 2018·Application pending·0 cites
- 2557US2025339572A1Solution Loaded with Alpha-Emitter RadionuclidesALPHA TAU MEDICAL LTD·Filed 2025·Application pending·0 cites
- 2656US2023264044A1Convection-Enhanced Diffusing Alpha-Emitter Radiation TherapyALPHA TAU MEDICAL LTD·Filed 2023·Application pending·0 cites
- 2755US11666781B2Treatment planning for alpha particle radiotherapyALPHA TAU MEDICAL LTD·Filed 2021·Granted Jun 6, 2023·0 cites·33 claims
- 2847US2025228986A1Diffusing Alpha-Emitter Radiation Therapy for Lung CancerALPHA TAU MEDICAL LTD·Filed 2025·Application pending·0 cites
- 2946US2022395700A1Diffusing alpha-emitter radiation therapy for colon cancerALPHA TAU MEDICAL LTD·Filed 2021·Application pending·0 cites
- 3046US2022401755A1Diffusing alpha-emitter radiation therapy for squamous cell carcinomaALPHA TAU MEDICAL LTD·Filed 2021·Application pending·0 cites
- 3146US2022395703A1Activity levels for diffusing alpha-emitter radiation therapyALPHA TAU MEDICAL LTD·Filed 2021·Application pending·0 cites
- 3246US2022395702A1Diffusing alpha-emitter radiation therapy for glioblastomaALPHA TAU MEDICAL LTD·Filed 2021·Application pending·0 cites
- 3346US2022395704A1Diffusing alpha-emitter radiation therapy for melanomaALPHA TAU MEDICAL LTD·Filed 2021·Application pending·0 cites
- 3446US2022395706A1Diffusing alpha-emitter radiation therapy for breast and prostate cancerALPHA TAU MEDICAL LTD·Filed 2021·Application pending·0 cites
- 3546US2022395701A1Diffusing alpha-emitter radiation therapy for pancreatic cancerALPHA TAU MEDICAL LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lior Arazi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →